Keeping investors in touch
AstraZeneca Investor Relations iPad app
The AstraZeneca Investor Relations iPad app provides instant access to our latest news, webcasts and presentations, events and leadership videos.
Notifications will keep you up to date with the most recent updates from AstraZeneca and synchronise to your device for reference.
Q3 2013 investor presentation
Download our interactive investor presentation to review our latest financial information, product performance and see progress on our development pipeline of potential new medicines.Investor Relations interactive presentation (PDF 13705kb)
MedImmune R&D Roadshow
Third quarter and nine months results 2013
Second quarter results 2013
First quarter results 2013
Annual Report 2012
Currency guidance 2013
In order to help analysts and investors estimate the impact of changing exchange rates on sales and earnings, the Company provides an annual 'currency sensitivity guide', alongside the rates upon which its earnings guidance is based.
The latest guide, intended to help estimate the impact of currency movements for 2013, is an update of the 2012 guidance given in January 2012.
Definition of Core Financial Measures
Definition of Core Financial Measures will change with effect from Q1 2013.
Annual information update
This update relates to information that has been published or made available to the public between 8 April 2011 and 10 April 2012.Annual information update 2012 (PDF 73kb)